徐州租人睡觉过夜APP哪个好-徐州租人睡觉过夜APP哪个好_首页

在临沧酒店晚上怎么叫服务

Welcome to the official website of Yantai Dongcheng Pharmaceutical Group Co., Ltd!
Stock Code: 002675
Introduction to Dongcheng
Your current position: home page >> About Dongcheng >>Introduction to Dongcheng

Yantai Dongcheng Pharmaceutical Group Co., Ltd. (formerly Yantai Dongcheng Biochemical Co., Ltd.) was established in 1998 and successfully landed in Shenzhen Stock Exchange in May 2012. After nearly 20 years of accumulation and development, Dongcheng pharmaceutical has developed into a large pharmaceutical enterprise group covering biochemical raw materials, Chinese patent medicine, chemical medicine and nuclear medicine, integrating drug R & D, production and sales.

      The group holds a number of subsidiaries: Yantai Dongcheng north pharmaceutical Co., Ltd., Yantai Dongcheng Dayang Pharmaceutical Co., Ltd., Linyi Dongcheng Dongyuan Bioengineering Co., Ltd., Dongcheng Pharmaceutical (USA) Co., Ltd., Dongcheng International (Hong Kong) Co., Ltd., Chengdu Yunke Pharmaceutical Co., Ltd., Dongcheng Xinke, Zhongtai biological products Co., Ltd., Shanghai Yitai Pharmaceutical Technology Co., Ltd The group has established R & D branches and offices in Beijing and Shanghai with more than 1000 employees.        

As one of the production bases of biochemical raw materials in China, more than 90% of the raw drug products heparin sodium and chondroitin sulfate are sold to more than 30 countries and regions such as the European Union, America, Asia Pacific and so on, and has established long-term and stable cooperative relations with many well-known pharmaceutical enterprises in the world.  

Dongcheng Pharmaceutical Co., Ltd. has continuously strengthened the development of its preparation business. Its subsidiaries, Dongcheng Dayang and Dongcheng north, have prepared products covering cardiovascular, anti-tumor, urinary, orthopedic and anti infection treatment fields. In recent years, the company has entered the nuclear medicine industry with high technical barriers and high growth. It has successively acquired Chengdu Yunke Pharmaceutical Co., Ltd., Shanghai Yitai Pharmaceutical Co., Ltd., Dongcheng Xinke Pharmaceutical Co., Ltd., and Nanjing Jiangyuan Andico co Co., Ltd., completing the whole industrial chain layout of the company from diagnostic nuclear drugs to therapeutic nuclear drugs, thus laying the company's position in the field of nuclear medicine in China.  

Dongcheng pharmaceutical has continuously increased investment in scientific research, committed to independent innovation, and constantly introduced high-quality talents such as Taishan Scholars and 973 scientists. Through the establishment of a wide range of international cooperation network, to achieve the introduction and transformation of new technologies, leading enterprises to continue transformation and upgrading. The company has won the honorary titles of "key high-tech enterprise of national Torch Plan", "export innovation base of Shandong science and technology development trade", "provincial enterprise technology center" and "provincial engineering technology center".  

      Under the guidance of the enterprise mission of "based on the East, honest and healthy", Dongcheng pharmaceutical will adhere to the business philosophy of "stable operation, sustainable development, market orientation, customer first, responsibility Dongcheng, benefit Dongcheng", deepen the resource integration, optimize the industrial structure, continuously improve the innovation ability and core competitiveness of the enterprise, join hands with the elite team to serve human health, and constantly achieve success Long for the professional field, continue to create outstanding value pharmaceutical enterprises step forward.

 

 

 
contact us CONTACT US
0535-6391521
Switchboard: 86-535-6391521 / 6391522
Email: zxu @ midatlanticlegends.com
Address: No.7 Changbaishan Road, Yantai Development Zone, Shandong Province
Copyright 2014 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All Rights Reserved Lu ICP Bei 18035060-1